Watanabe H, Sanada H, Shigetomi S, Katoh T, Watanabe T
Third Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan.
Nephron. 2000 Sep;86(1):27-35. doi: 10.1159/000045709.
This study was carried out to clarify whether the urinary excretion of type IV collagen (u-IV collagen) detected by specific radioimmunoassay, can be used as an indicator for the progression of diabetic nephropathy.
u-IV collagen was higher in diabetic subjects with microalbuminuria and overt proteinuria than those with normoalbuminuria, IgA nephropathy, membranoproliferative glomerulonephritis, membranous nephropathy, or control normal subjects. u-IV collagen was positively correlated with serum and urinary beta(2)-microglobulin and negatively with creatinine clearance only in diabetic patients, but not in patients with other glomerular diseases. The serum type IV collagen was not different between all the groups, and not correlated with its urinary excretion. In the advanced diabetic nephropathy, immunoreactive type IV collagen was detected in glomerular basement membrane (GBM), tubular basement membrane and Bowman's capsule much more than that in the normal kidney.
These findings indicated increased production and degeneration of type IV collagen in diabetic nephropathy. It is suggested that augmented turnover of type IV collagen in GBM and tubular basement membrane results in increased concentrations of free u-IV collagen. Therefore, measurement of u-IV collagen may be a useful, specific indicator of the progression of diabetic nephropathy.
开展本研究以阐明通过特异性放射免疫测定法检测的IV型胶原尿排泄量(u-IV胶原)是否可作为糖尿病肾病进展的指标。
与正常白蛋白尿、IgA肾病、膜增生性肾小球肾炎、膜性肾病患者或正常对照受试者相比,微量白蛋白尿和显性蛋白尿的糖尿病患者u-IV胶原水平更高。仅在糖尿病患者中,u-IV胶原与血清及尿β2微球蛋白呈正相关,与肌酐清除率呈负相关,而在其他肾小球疾病患者中无此相关性。所有组间血清IV型胶原无差异,且与尿排泄量无相关性。在晚期糖尿病肾病中,肾小球基底膜(GBM)、肾小管基底膜和鲍曼囊中的免疫反应性IV型胶原比正常肾脏中检测到的要多得多。
这些发现表明糖尿病肾病中IV型胶原的产生增加和降解。提示GBM和肾小管基底膜中IV型胶原周转增加导致游离u-IV胶原浓度升高。因此,测定u-IV胶原可能是糖尿病肾病进展的一个有用的特异性指标。